Global /South Korea /Healthcare /Biotechnology /298060

Poongjeon Pharmacy CO.,LTD.

298060

• KRX: 298060 • Delayed

4,635KRW 2.1%

3.05 USD

As of 17 June 2026, Poongjeon Pharmacy CO.,LTD. has a market cap of $27.05M USD, ranking #35003 globally and #2184 in South Korea. It ranks #3160 in the Healthcare sector, and #609 in the Biotechnology industry.

Global Rank

35003

Country Rank

2184

Sector Rank

3160

Industry Rank

609

Key Stats

Market Cap

$27.05MUSD

40.98B KRW

Enterprise Value

$21.13MUSD

32.08B KRW

Revenue (TTM)

$1.02MUSD

1.54B KRW

EBITDA (TTM)

-$4.84MUSD

-7.35B KRW

Net Income (TTM)

-$5.44MUSD

-8.24B KRW

PS Ratio

26.6

PB Ratio

1.7

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Biotechnology

CEO

Byeong-gwan Son open_in_new

Founded

2014

Website

scmlifescience.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.1%	5.5%	19%	17%	-12%	-8.4%	-6.7%	-91%	-97%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	298060 에스씨엠생명과학(주) Ordinary Shares ISIN: KR7298060005 Shares Out.: Shares Outstanding: 8.839M¹ Shares Float: 8.41M² TV: TradingView: KRX: 298060 SA: Stock Analysis: KRX: 298060 YF: Yahoo Finance: 298060.KS GF: Google Finance: KRX: 298060 BA: Barron's: 298060 MS: Morningstar: XKRX: 298060	4,635 KRW	TV: TradingView: KRX: 298060 SA: Stock Analysis: KRX: 298060 YF: Yahoo Finance: 298060.KS GF: Google Finance: KRX: 298060 BA: Barron's: 298060 MS: Morningstar: XKRX: 298060

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Poongjeon Pharmacy CO.,LTD.

POONGJEON PHARMACY CO.,LTD. operates as a stem cell therapy company in South Korea. It develops SCM-AGH, a treatment for moderate to severe acute pancreatitis and moderate to severe atopic dermatitis, as well as chronic graft versus host disease; and Iroro Deerscalp, a toothbrush cosmetic for hair loss relief. The company was formerly known as SCM Lifescience Co., Ltd. and change its name to POONGJEON PHARMACY CO.,LTD. in April 2026. The company was incorporated in 2014 and is headquartered in Incheon, South Korea.

Similar Companies

Industry: Biotechnology (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Biologics Co.,Ltd. KRX: 207940	$45.02B 68.19T KRW 166K%	35.5	South Korea
Celltrion, Inc. KRX: 068270	$28.23B 42.76T KRW 104K%	43.8	South Korea
ALTEOGEN Inc. KRX: 196170	$13.43B 20.33T KRW 50K%	146.6	South Korea
HLB Co., Ltd. KRX: 028300	$5.53B 8.37T KRW 20K%	-	South Korea
Peptron, Inc. KRX: 087010	$4.01B 6.07T KRW 15K%	-	South Korea
SK bioscience Co.,Ltd. KRX: 302440	$2.26B 3.42T KRW 8K%	-	South Korea

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 674K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 591K%	19.0	United States
argenx SE EBR: ARGX	$47.99B 41.39B EUR 177K%	39.9	Netherlands
CSL Ltd. ASX: CSL	$42.64B 60.27B AUD 157K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.46B 33.71B CHF 157K%	37.2	Switzerland
Natera, Inc. NASDAQ: NTRA	$27.6B 102K%	-	United States

chevron_leftBack